BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 27182834)

  • 1. The Presence and Anti-HIV-1 Function of Tenascin C in Breast Milk and Genital Fluids.
    Mansour RG; Stamper L; Jaeger F; McGuire E; Fouda G; Amos J; Barbas K; Ohashi T; Alam SM; Erickson H; Permar SR
    PLoS One; 2016; 11(5):e0155261. PubMed ID: 27182834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tenascin-C is an innate broad-spectrum, HIV-1-neutralizing protein in breast milk.
    Fouda GG; Jaeger FH; Amos JD; Ho C; Kunz EL; Anasti K; Stamper LW; Liebl BE; Barbas KH; Ohashi T; Moseley MA; Liao HX; Erickson HP; Alam SM; Permar SR
    Proc Natl Acad Sci U S A; 2013 Nov; 110(45):18220-5. PubMed ID: 24145401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants of Tenascin-C and HIV-1 envelope binding and neutralization.
    Mangan RJ; Stamper L; Ohashi T; Eudailey JA; Go EP; Jaeger FH; Itell HL; Watts BE; Fouda GG; Erickson HP; Alam SM; Desaire H; Permar SR
    Mucosal Immunol; 2019 Jul; 12(4):1004-1012. PubMed ID: 30976088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secretory anti-human immunodeficiency virus (HIV) antibodies in colostrum and breast milk are not a major determinant of the protection of early postnatal transmission of HIV.
    Becquart P; Hocini H; Lévy M; Sépou A; Kazatchkine MD; Bélec L
    J Infect Dis; 2000 Feb; 181(2):532-9. PubMed ID: 10669336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compartmentalization of the IgG immune response to HIV-1 in breast milk.
    Becquart P; Hocini H; Garin B; Sépou A; Kazatchkine MD; Bélec L
    AIDS; 1999 Jul; 13(11):1323-31. PubMed ID: 10449284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maternal but Not Infant Anti-HIV-1 Neutralizing Antibody Response Associates with Enhanced Transmission and Infant Morbidity.
    Ghulam-Smith M; Olson A; White LF; Chasela CS; Ellington SR; Kourtis AP; Jamieson DJ; Tegha G; van der Horst CM; Sagar M
    mBio; 2017 Oct; 8(5):. PubMed ID: 29066544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutralization of HIV subtypes A and D by breast milk IgG from women with HIV infection in Uganda.
    Palaia JM; McConnell M; Achenbach JE; Gustafson CE; Stoermer KA; Nolan M; Guay LA; Leitner TK; Matovu F; Taylor AW; Fowler MG; Janoff EN
    J Infect; 2014 Mar; 68(3):264-72. PubMed ID: 24239588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rare Detection of Antiviral Functions of Polyclonal IgA Isolated from Plasma and Breast Milk Compartments in Women Chronically Infected with HIV-1.
    Tay MZ; Kunz EL; Deal A; Zhang L; Seaton KE; Rountree W; Eudailey JA; Heptinstall J; McRaven MD; Matias E; McGuire E; Yates NL; Perez LG; Montefiori DC; Overman RG; Hope TJ; Shen X; Kalilani L; Fouda GG; Tomaras GD; Permar SR
    J Virol; 2019 Apr; 93(7):. PubMed ID: 30700599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutralizing monoclonal antibodies to human immunodeficiency virus type 1 do not inhibit viral transcytosis through mucosal epithelial cells.
    Chomont N; Hocini H; Gody JC; Bouhlal H; Becquart P; Krief-Bouillet C; Kazatchkine M; Bélec L
    Virology; 2008 Jan; 370(2):246-54. PubMed ID: 17920650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-1 gp41-specific monoclonal mucosal IgAs derived from highly exposed but IgG-seronegative individuals block HIV-1 epithelial transcytosis and neutralize CD4(+) cell infection: an IgA gene and functional analysis.
    Tudor D; Derrien M; Diomede L; Drillet AS; Houimel M; Moog C; Reynes JM; Lopalco L; Bomsel M
    Mucosal Immunol; 2009 Sep; 2(5):412-26. PubMed ID: 19587640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined HIV-1 Envelope Systemic and Mucosal Immunization of Lactating Rhesus Monkeys Induces a Robust Immunoglobulin A Isotype B Cell Response in Breast Milk.
    Nelson CS; Pollara J; Kunz EL; Jeffries TL; Duffy R; Beck C; Stamper L; Wang M; Shen X; Pickup DJ; Staats HF; Hudgens MG; Kepler TB; Montefiori DC; Moody MA; Tomaras GD; Liao HX; Haynes BF; Ferrari G; Fouda GGA; Permar SR
    J Virol; 2016 May; 90(10):4951-4965. PubMed ID: 26937027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-specific functional antibody responses in breast milk mirror those in plasma and are primarily mediated by IgG antibodies.
    Fouda GG; Yates NL; Pollara J; Shen X; Overman GR; Mahlokozera T; Wilks AB; Kang HH; Salazar-Gonzalez JF; Salazar MG; Kalilani L; Meshnick SR; Hahn BH; Shaw GM; Lovingood RV; Denny TN; Haynes B; Letvin NL; Ferrari G; Montefiori DC; Tomaras GD; Permar SR;
    J Virol; 2011 Sep; 85(18):9555-67. PubMed ID: 21734046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recognition properties of a panel of human recombinant Fab fragments to the CD4 binding site of gp120 that show differing abilities to neutralize human immunodeficiency virus type 1.
    Roben P; Moore JP; Thali M; Sodroski J; Barbas CF; Burton DR
    J Virol; 1994 Aug; 68(8):4821-8. PubMed ID: 7518527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of HIV-1 Envelope-Specific Breast Milk IgA Responses with Reduced Risk of Postnatal Mother-to-Child Transmission of HIV-1.
    Pollara J; McGuire E; Fouda GG; Rountree W; Eudailey J; Overman RG; Seaton KE; Deal A; Edwards RW; Tegha G; Kamwendo D; Kumwenda J; Nelson JA; Liao HX; Brinkley C; Denny TN; Ochsenbauer C; Ellington S; King CC; Jamieson DJ; van der Horst C; Kourtis AP; Tomaras GD; Ferrari G; Permar SR
    J Virol; 2015 Oct; 89(19):9952-61. PubMed ID: 26202232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation of HIV-1-neutralizing mucosal monoclonal antibodies from human colostrum.
    Friedman J; Alam SM; Shen X; Xia SM; Stewart S; Anasti K; Pollara J; Fouda GG; Yang G; Kelsoe G; Ferrari G; Tomaras GD; Haynes BF; Liao HX; Moody MA; Permar SR
    PLoS One; 2012; 7(5):e37648. PubMed ID: 22624058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Broadly Neutralizing Antibodies Display Potential for Prevention of HIV-1 Infection of Mucosal Tissue Superior to That of Nonneutralizing Antibodies.
    Cheeseman HM; Olejniczak NJ; Rogers PM; Evans AB; King DFL; Ziprin P; Liao HX; Haynes BF; Shattock RJ
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27795431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutralizing as well as non-neutralizing polyclonal immunoglobulin (Ig)G from infected patients capture HIV-1 via antibodies directed against the principal immunodominant domain of gp41.
    Burrer R; Haessig-Einius S; Aubertin AM; Moog C
    Virology; 2005 Mar; 333(1):102-13. PubMed ID: 15708596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human IgM monoclonal antibodies block HIV-transmission to immune cells in cervico-vaginal tissues and across polarized epithelial cells in vitro.
    Devito C; Ellegård R; Falkeborn T; Svensson L; Ohlin M; Larsson M; Broliden K; Hinkula J
    Sci Rep; 2018 Jul; 8(1):10180. PubMed ID: 29977063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The function and affinity maturation of HIV-1 gp120-specific monoclonal antibodies derived from colostral B cells.
    Jeffries TL; Sacha CR; Pollara J; Himes J; Jaeger FH; Dennison SM; McGuire E; Kunz E; Eudailey JA; Trama AM; LaBranche C; Fouda GG; Wiehe K; Montefiori DC; Haynes BF; Liao HX; Ferrari G; Alam SM; Moody MA; Permar SR
    Mucosal Immunol; 2016 Mar; 9(2):414-27. PubMed ID: 26242599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic administration of an HIV-1 broadly neutralizing dimeric IgA yields mucosal secretory IgA and virus neutralization.
    Fouda GG; Eudailey J; Kunz EL; Amos JD; Liebl BE; Himes J; Boakye-Agyeman F; Beck K; Michaels AJ; Cohen-Wolkowiez M; Haynes BF; Reimann KA; Permar SR
    Mucosal Immunol; 2017 Jan; 10(1):228-237. PubMed ID: 27072605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.